Skip to main content
SpringerLink
Log in

Bone quality is partially recovered after the discontinuation of RANKL administration in rats by increased bone mass on existing trabeculae: an in vivo micro-CT study

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

Bone loss and recovery in a receptor activator for nuclear factor κ B ligand (RANKL)-administered rat model was assessed. Microarchitecture, mineralization and strength deteriorated faster than ovariectomy (OVX). Recovery was dependent on the loss of trabecular elements and connections. Early recovery suggests a natural mechanism in rats to overcome excess RANKL, and may have implications for long-term bone loss.

Purpose

To compare a model for experimental osteoporosis that induces bone loss by injecting RANKL into rats to an OVX rat model, and measure subsequent recovery of bone architecture, mineralization, and mechanics after stopping injections.

Methods

Mature, healthy, female Wistar rats were divided into high-dose RANKL, low-dose RANKL, OVX, and vehicle control groups. The right proximal tibiae were micro-computed tomography (micro-CT) scanned in vivo every 2 weeks from week 0 to week 12 and every 4 weeks from week 12 to week 20. Bone architectural, mineralization, and mechanical changes were determined. Serum calcium, RANKL, anti-RANKL, and osteoprotegerin were measured at weeks 0, 6, and 20.

Results

High-dose RANKL administration resulted in severe deterioration of the trabecular architecture (39% of baseline BV/TV), and modest decreases in tissue mineralization, bone mass, and stiffness. Bone loss occurred more rapidly than in the OVX and low-dose RANKL group, and recovery occurred prior to stopping RANKL injections. Full recovery of trabecular thickness, tissue mineralization, and cortical bone mass, partial recovery of trabecular bone volume (55% of baseline), structural model index, bone mass (69% of baseline), and stiffness (90% of baseline) but no improvement in connectivity density or trabecular number was observed.

Conclusion

RANKL administration resulted in rapid and dose-dependent bone loss. The recovery of trabecular bone volume and stiffness appeared to be dependent on the number of remaining trabecular elements and their interconnections. Uncontrolled recovery suggests that further investigation into the RANKL-injected rat as a model of bone loss is required.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Manolagas SC (2000) Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21:115–137

    Article  CAS  PubMed  Google Scholar 

  2. Teitelbaum S (2000) Bone resorption by osteoclasts. Science 289:1504–1508

    Article  CAS  PubMed  Google Scholar 

  3. Marx J (2004) Coming to grips with bone loss. Science 305:1420–1422

    Article  CAS  PubMed  Google Scholar 

  4. (2001) Osteoporosis prevention, diagnosis, and therapy. Jama 285:785-795.

  5. Kostenuik PJ (2005) Ostoprotegeren and RANKL regulate bone resorption, density, geometry and strength. Curr Opin in Pharmacol 5:618–625

    Article  CAS  Google Scholar 

  6. Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E (1999) Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci 96:3540–3545

    Article  CAS  PubMed  Google Scholar 

  7. Hofbauer LC, Schoppet M (2004) Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA 292:490–495

    Article  CAS  PubMed  Google Scholar 

  8. Aufdemorte T, Boyan B, Fox C, Miller D (1993) Diagnostic tools and biological markers: animal models in the study of osteoporosis and oral bone loss. Journal of Bone and Mineral Research 8:S529–534

    Article  PubMed  Google Scholar 

  9. Dempster DW, Birchman R, Xu R, Lindsay R, Shen V (1995) Temporal changes in cancellous bone structure of rats immediately after ovariectomy. Bone 16:157–161

    CAS  PubMed  Google Scholar 

  10. Campbell GM, Buie HR, Boyd SK (2008) Signs of irreversible architectural changes occur early in the development of experimental osteoporosis as assessed by in vivo micro-CT. Osteoporos Int 19:1409–1419

    Article  CAS  PubMed  Google Scholar 

  11. Boyd SK, Davison P, Mueller R, Gasser JA (2006) Monitoring individual morphological changes over time in ovariectomized rats by invivo micro computed tomography. Bone 39:854–862

    Article  PubMed  Google Scholar 

  12. Ominsky MS, Li X, Asuncion FJ, Barrero M, Warmington KS, Dwyer D, Stolina M, Geng Z, Grisanti M, Tan HL, Corbin T, McCabe J, Simonet WS, Ke HZ, Kostenuik PJ (2008) RANKL inhibition with osteoprotegerin increases bone strength by improving cortical and trabecular bone architecture in ovariectomized rats. J Bone Miner Res 23:672–682

    Article  CAS  PubMed  Google Scholar 

  13. Lloyd SA, Yuan YY, Kostenuik PJ, Ominsky MS, Lau AG, Morony S, Stolina M, Asuncion FJ, Bateman TA (2008) Soluble RANKL induces high bone turnover and decreases bone volume, density, and strength in mice. Calcif Tissue Int 82:361–372

    Article  CAS  PubMed  Google Scholar 

  14. Yuan YY, Kostenuik PJ, Ominsky MS, Morony S, Adamu S, Simionescu DT, Basalyga DM, Asuncion FJ, Bateman TA (2008) Skeletal deterioration induced by RANKL infusion: a model for high turnover bone disease. Osteoporos Int 19:625–635

    Article  CAS  PubMed  Google Scholar 

  15. Tomimori Y, Mori K, Koide M, Nakamichi Y, Ninomiya T, Udagawa N, Yasuda H (2009) Evaluation of pharmaceuticals with a novel 50-hour animal model of bone loss. J Bone Miner Res 24:1194–1205

    Article  CAS  PubMed  Google Scholar 

  16. Hofbauer LC, Heufelder AE (2001) Role of receptor activator of nuclear factor kappaB ligand and osteoprotegerin in bone cell biology. J Mol Med 79:243–253

    Article  CAS  PubMed  Google Scholar 

  17. Theoleyre S, Wittrant Y, Tat SK, Fortun Y, Redini F, Heymann D (2004) The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev 15:457–475

    Article  CAS  PubMed  Google Scholar 

  18. Brouwers JE, van Rietbergen B, Huiskes R (2007) No effects of in vivo micro-CT radiation on structural parameters and bone marrow cells in proximal tibia of wistar rats detected after eight weekly scans. J Orthop Res 25:1325–1332

    Article  PubMed  Google Scholar 

  19. Klinck RJ, Campbell GM, Boyd SK (2007) Radiation effects on bone structure in mice and rats resulting from in vivo micro-computed tomography scanning. Med Eng Phys 30:888–895

    Article  Google Scholar 

  20. Laib A, Kumer JL, Majumdar S, Lane NE (2001) The temporal changes of trabecular architecture in ovariectomized rats assessed by MicroCT. Osteoporos Int 12:936–941

    Article  CAS  PubMed  Google Scholar 

  21. Hildebrand T, Rüegsegger P (1997) A new method for the model-independent assessment of thickness in three-dimensional images. J Microsc 185:67–75

    Article  Google Scholar 

  22. Odgaard A (1997) Three-dimensional methods for quantification of cancellous bone architecture. Bone 20:315–328

    Article  CAS  PubMed  Google Scholar 

  23. Odgaard A, Gundersen HJ (1993) Quantification of connectivity in cancellous bone, with special emphasis on 3-D reconstructions. Bone 14:173–182

    Article  CAS  PubMed  Google Scholar 

  24. Hildebrand T, Ruegsegger P (1997) Quantification of bone microarchitecture with the structure model index. Comput Methods Biomech Biomed Engin 1:15–23

    Article  PubMed  Google Scholar 

  25. Boyd S, Moser S, Kuhn M, Klinck R, Krauze P, Müller R, Gasser J (2006) Evaluation of three-dimensional image registration methodologies for in vivo micro-computed tomography. Annals of Biomedical Engineering 34:1587–1599

    Article  PubMed  Google Scholar 

  26. van Rietbergen B, Weinans H, Huiskes R, Odgaard A (1995) A new method to determine trabecular bone elastic properties and loading using micromechanical finite element models. J Biomech 28:69–81

    Article  PubMed  Google Scholar 

  27. Su R, Campbell GM, Boyd SK (2006) Establishment of an architecture-specific experimental validation approach for finite element modeling of bone by rapid prototyping and high resolution computed tomography. Medical Engineering and Physics 29:480–490

    Article  PubMed  Google Scholar 

  28. Li X, Ominsky MS, Stolina M, Warmington KS, Geng Z, Niu QT, Asuncion FJ, Tan HL, Grisanti M, Dwyer D, Adamu S, Ke HZ, Simonet WS, Kostenuik PJ (2009) Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin. Bone 45:669–676

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors wish to acknowledge the technical support of Mr. Jeffrey Louie for his assistance with the architectural analysis, Ms. Joan Miller for her assistance with the preparations of the injections, and Dr. Marina Stolina and Ms. Denise Dwyer for their assistance with the serum bioassays. Additionally, we would like to acknowledge the funding provided by the Canadian Institutes of Health Research and the Alberta Heritage Foundation for Medical Research.

Conflict of interest

None

Author information

Authors and Affiliations

  1. Department of Mechanical and Manufacturing Engineering, University of Calgary, 2500 University Drive, NW, Calgary, AB, T2N 1N4, Canada

    Graeme M. Campbell & Steven K. Boyd

  2. Roger Jackson Centre for Health and Wellness Research, University of Calgary, Calgary, Canada

    Graeme M. Campbell & Steven K. Boyd

  3. Department of Metabolic Disorders, Amgen Inc, Thousand Oaks, CA, USA

    Michael S. Ominsky

Authors
  1. Graeme M. Campbell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael S. Ominsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Steven K. Boyd
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steven K. Boyd.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Campbell, G.M., Ominsky, M.S. & Boyd, S.K. Bone quality is partially recovered after the discontinuation of RANKL administration in rats by increased bone mass on existing trabeculae: an in vivo micro-CT study. Osteoporos Int 22, 931–942 (2011). https://doi.org/10.1007/s00198-010-1283-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-010-1283-5

Keywords

Search

Navigation